Finance

Lists
Why is URGN down 4,39%?
Dive Deeper
URGN:NASDAQ
Urogen Pharma Ltd
36,58 US$
-4,39%
(-1,68) 1D
36,58 US$
0,00% (0,00)
After hours
Closed: 14 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
37,96 US$
High
39,09 US$
Low
36,44 US$
Mkt. cap
1,79 მლრდ.
Avg. vol.
887,34 ათ.
Volume
0,00
52-wk high
50,81 US$
52-wk low
16,36 US$
EPS
-1,98 US$
Beta
1,57
Shares outstanding
48,88 მლნ.
No. of employees
300
Open
37,96 US$
High
39,09 US$
Low
36,44 US$
Mkt. cap
1,79 მლრდ.
Avg. vol.
887,34 ათ.
Volume
0,00
52-wk high
50,81 US$
52-wk low
16,36 US$
EPS
-1,98 US$
Beta
1,57
Shares outstanding
48,88 მლნ.
No. of employees
300
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
14 საათის წინ
(URGN) Risk Channels and Responsive Allocation
About Urogen Pharma Ltd
CEO-
Employees300
Founded2004
Headquartersნიუ-იორკი, ნიუ-იორკის შტატი, ამერიკის შეერთებული შტატები
Sector-
Websiteurogen.com
Analyst ratings
Based on 5 analysts giving stock ratings to URGN in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for URGN in the last 3 months.
Highest
Current 36,58 US$
75,00 US$ (+105,03%)
Average
60,20 US$ (+64,57%)
Lowest
48,00 US$ (+31,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
75,00 US$
+105%
08/21/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
60,00 US$
+64%
08/06/2026
Paul Choi
Goldman Sachs
Hold
Maintained
48,00 US$
+31,2%
08/05/2026
Michael Schmidt
Guggenheim
Buy
Maintained
58,00 US$
+58,6%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Reiterated
60,00 US$
+64%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
32,00 US$
-12,5%
06/03/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
43,00 US$
+17,6%
05/11/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
40,00 US$
+9,3%
04/20/2026
Amin Makarem
Jefferies
Buy
Initiated
40,00 US$
+9,3%
04/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
27,48 მლნ.
37,84 მლნ.
50,96 მლნ.
72,46 მლნ.
Cost of goods sold
3,28 მლნ.
3,29 მლნ.
4,14 მლნ.
6,57 მლნ.
Cost of revenue
3,28 მლნ.
3,29 მლნ.
4,14 მლნ.
6,57 მლნ.
Research and development expenses
14,01 მლნ.
14,31 მლნ.
15,60 მლნ.
17,34 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,58 მლნ.
39,35 მლნ.
51,49 მლნ.
48,44 მლნ.
Operating expense
51,59 მლნ.
53,66 მლნ.
67,08 მლნ.
65,77 მლნ.
Total operating expenses
54,87 მლნ.
56,95 მლნ.
71,22 მლნ.
72,34 მლნ.
Operating income
-27,39 მლნ.
-19,12 მლნ.
-20,26 მლნ.
111,00 ათ.
Other non operating income
-4,82 მლნ.
-4,66 მლნ.
-4,83 მლნ.
-4,89 მლნ.
EBT including unusual items
-34,40 მლნ.
-26,64 მლნ.
-28,35 მლნ.
-8,72 მლნ.
EBT excluding unusual items
-34,40 მლნ.
-26,64 მლნ.
-28,35 მლნ.
-8,72 მლნ.
Income tax expense
-1,05 მლნ.
-275,00 ათ.
-4,77 მლნ.
5,63 მლნ.
Effective tax rate
3,06%
1,03%
16,83%
-64,54%
Other operating expenses
-
-
-
-
Net income
-33,35 მლნ.
-26,36 მლნ.
-23,57 მლნ.
-14,35 მლნ.
Net profit margin
-121,34%
-69,68%
-46,26%
-19,81%
Earnings per share
-0,69
-0,53
-0,47
-0,28
Interest and investment income
1,18 მლნ.
908,00 ათ.
931,00 ათ.
946,00 ათ.
Interest expense
-3,37 მლნ.
-3,77 მლნ.
-4,18 მლნ.
-4,89 მლნ.
Net interest expenses
-2,20 მლნ.
-2,86 მლნ.
-3,25 მლნ.
-3,94 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,31 მლნ.
-19,04 მლნ.
-20,19 მლნ.
189,00 ათ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები